Patent · US Active

Matrix protein compositions for induction of apoptosis

US7960347B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

INSTITUT STRAUMANN AG · CH

Inventors

Lars Hammarstrom · Djursholm, SE
Ståle Petter Lyngstadaas · Nesoddtangen, NO
Stina Gestrelius · Lund, SE

Key dates

Filing date	Apr 14, 2010
Grant date	Jun 14, 2011
Priority date	—
Expiry date	Apr 14, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Enamel matrix, enamel matrix derivatives and/or enamel matrix proteins or peptides may be used as therapeutic or prophylactic agents for inducing programmed cell death (apoptosis), in particular in the treatment or prevention of cancer or malignant or benign neoplasms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.